|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash provided by (used for): | |||||
| Operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to total operating activities: | |||||
| Depreciation and amortization | |||||
| Deferred income taxes | |||||
| Share-based compensation expense | |||||
| Gain on sale of business/investment | |||||
| Gain on sale of facilities | |||||
| Changes in assets and liabilities, net of acquisitions: | |||||
| (Increase) decrease in receivables | |||||
| (Increase) decrease in inventories and other current assets | |||||
| (Decrease) increase in payables, accruals and income taxes | |||||
| Increase (decrease) in other long-term liabilities | |||||
| Pension contributions | |||||
| Other, net | |||||
| Total operating activities | |||||
| Investing activities: | |||||
| Additions to property, plant and equipment | |||||
| Purchases of businesses, net of cash acquired | |||||
| Proceeds from sale of business/investment | |||||
| Proceeds from sale of facilities | |||||
| Other, net | |||||
| Total investing activities | |||||
| Financing activities: | |||||
| Net change in short-term borrowings | |||||
| Repayments of long-term borrowings | |||||
| Repurchases of common stock | |||||
| Cash dividends paid | |||||
| Proceeds from stock option exercises | |||||
| Other, net | |||||
| Total financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents: | |||||
| Beginning of year | |||||
| End of year | |||||
Loading...